Abbott Laboratories
ABT
HK$1,062
Share price
0.86%
Change (1 day)
26.45%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Cash on Hand
Cash on Hand as of March 2025 : HK$53.71 Billion
According to Abbott Laboratories's latest financial reports the company has HK$53.71 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Abbott Laboratories - Cash on Hand chart (from 1996 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | HK$61.85 B | 8.8% |
| 2023-12-31 | HK$56.84 B | -28.46% |
| 2022-12-31 | HK$79.46 B | -0.57% |
| 2021-12-31 | HK$79.91 B | 44.22% |
| 2020-12-31 | HK$55.41 B | 71.86% |
| 2019-12-31 | HK$32.24 B | 0.77% |
| 2018-12-31 | HK$31.99 B | -57.38% |
| 2017-12-31 | HK$75.08 B | -48.43% |
| 2016-12-31 | HK$145.59 B | 206.68% |
| 2015-12-31 | HK$47.47 B | 37.23% |
| 2014-12-31 | HK$34.59 B | -44.91% |
| 2013-12-31 | HK$62.79 B | -46.61% |
| 2012-12-31 | HK$117.61 B | 87.02% |
| 2011-12-31 | HK$62.89 B | 48.24% |
| 2010-12-31 | HK$42.42 B | -44.91% |
| 2009-12-31 | HK$77.01 B | 96.19% |
| 2008-12-31 | HK$39.25 B | 78.47% |
| 2007-12-31 | HK$21.99 B | 105.9% |
| 2006-12-31 | HK$10.68 B | -53.39% |
| 2005-12-31 | HK$22.91 B | 43.24% |
| 2004-12-31 | HK$16.00 B | 60.47% |
| 2003-12-31 | HK$9.97 B | 32.34% |
| 2002-12-31 | HK$7.53 B | 35.41% |
| 2001-12-31 | HK$5.56 B | -38.33% |
| 2000-12-31 | HK$9.02 B | 60.55% |
| 1999-12-31 | HK$5.61 B | 76.47% |
| 1998-12-31 | HK$3.18 B | 78.65% |
| 1997-12-31 | HK$1.78 B | 109.11% |
| 1996-12-31 | HK$0.85 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | HK$304.39 B | 466.64% | 🇺🇸 USA |
 Pfizer PFE | HK$135.91 B | 153.01% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | HK$46.67 B | -13.11% | 🇺🇸 USA |
 Hologic HOLX | HK$12.72 B | -76.32% | 🇺🇸 USA |
 Medtronic MDT | HK$62.18 B | 15.75% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | HK$92.47 B | 72.15% | 🇺🇸 USA |
 Boston Scientific BSX | HK$5.69 B | -89.41% | 🇺🇸 USA |
 AstraZeneca AZN | HK$42.34 B | -21.17% | 🇬🇧 UK |
 Novartis NVS | HK$56.48 B | 5.14% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | HK$45.54 B | -15.21% | 🇬🇧 UK |